Lee Wrubel, MD
Lee Wrubel, MD, is a Managing Partner for Foundation Medical Partners. Dr. Wrubel has ten years of experience in venture capital and has been associated with a large number of private companies, including such now publicly traded companies as Pozen Pharmaceuticals, OraPharma, and GenVec. Prior to starting Foundation Medical Partners, Dr. Wrubel was an investment professional with Canaan Partners and more recently Highland Capital Partners, where he specialized in biotechnology and medical device investments. Dr. Wrubel serves on the board of directors of CardioMEMS, Inc., Circulite, Inc., Direct Flow Medical, Inc., EndoGastric Solutions, Inc., IlluminOss, and Rise Health, Inc.
Dr. Wrubel began his business career as a consultant at The Wilkerson Group, a healthcare-focused management consulting company. Dr. Wrubel completed a pediatric internship at Mount Sinai Medical Center in New York. He holds an AB from Lafayette College, an MD and MS in public health from Tufts University, and an MBA from Columbia University.
Dr. Wrubel serves on the Translational Research Advisory Committee of the Muscular Dystrophy Association, is a member of the Health Leadership Council of Save The Children and serves on the Board of Governors for the Rhode Island School of Design (RISD) Museum.